Sort
39,280 grants matching “leukemia”
Administrative Core
$484,747Sumithra Jay Mandrekar · Mayo Clinic Rochester · U10 · FY2023 · CA
Type 1 diabetes: the role of commensal microbiota
$484,709Alexander V Chervonsky · University Of Chicago · R01 · FY2018 · AI
Type 1 diabetes: the role of commensal microbiota
$484,709Alexander V Chervonsky · University Of Chicago · R01 · FY2019 · AI
Type 1 diabetes: the role of commensal microbiota
$484,709Alexander V Chervonsky · University Of Chicago · R01 · FY2020 · AI
Type 1 diabetes: the role of commensal microbiota
$484,709Alexander V Chervonsky · University Of Chicago · R01 · FY2017 · AI
Immunology And Pathology Of Acute and Chronic Murine Leukemia Virus Infections
$484,686Kim Hasenkrug · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Animal models to study the role of INK4b loss in human acute myeloid leukemia
$484,683Linda Wolff · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
CYP33 in MLL TARGET GENE REGULATION AND LEUKEMOGENESIS
$484,670Manuel O Diaz · Loyola University Chicago · P01 · FY2007 · CA
Transporters and hematopoietic toxicity
$484,566John D Schuetz · St. Jude Children'S Research Hospital · R01 · FY2018 · CA
Transporters and hematopoietic toxicity
$484,566John D Schuetz · St. Jude Children'S Research Hospital · R01 · FY2020 · CA
Good Manufacturing Practice (GMP) and Immune Assessment Core
$484,556Elizabeth J Shpall · University Of Tx Md Anderson Can Ctr · P01 · FY2013 · CA
ALDH Activation to treat Fanconi Anemia
$484,430Kenneth I. Weinberg · Stanford University · R01 · FY2019 · HL
Investigating and targeting NSD2 mutation-driven leukemia transformation
$484,405Jianping Li · Thomas Jefferson University · R37 · FY2025 · CA
Targeted Radiotherapy of Neoplastic Meningitis using Monoclonal Antibodies Label
$484,382Michael Rod Zalutsky · Duke University · P01 · FY2014 · CA
Neurofibromatosis Type 1 Gene Regulates Myelopoiesis
$484,270Indiana Univ-Purdue Univ At Indianapolis · R01 · FY2003 · CA
OCG Data Coordinating Center
$484,259Leonard Freedman · Leidos Biomedical Research, Inc. · N01 · FY2020 · CA
MOLECULAR PATHOLOGY OF LYMPHOID MALIGNANCIES
$484,230Stanford University · R37 · FY2001 · CA
INORGANIC ION EXCHANGERS FOR 213 BI GENERATORS
$484,097Lynntech, Inc. · R44 · FY2002 · CA
Statistical methods for analysis of single-cell variability
$484,021Peter V Kharchenko · Harvard Medical School · R01 · FY2016 · HL
Statistical methods for analysis of single-cell variability
$484,021Peter V Kharchenko · Harvard Medical School · R01 · FY2019 · HL
Statistical methods for analysis of single-cell variability
$484,021Peter V Kharchenko · Harvard Medical School · R01 · FY2018 · HL
Statistical methods for analysis of single-cell variability
$484,021Peter V Kharchenko · Harvard Medical School · R01 · FY2017 · HL
Immune reconstitution following autologous and allogeneic stem cell transplant
$483,898Jeremy Rose · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA
PROCESSED ANTIGEN CHARACTERIZATION BY MASS SPECTROMETRY
$483,799University Of Virginia Charlottesville · R37 · FY2002 · AI
Mechanisms of resistance to ponatinib therapy in chronic myeloid leukemia
$483,771Thomas J. O'Hare · University Of Utah · R01 · FY2018 · CA